PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77022F0026Abaloparatide — Radius Health, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Nov 12, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Cmop Office (36C770)
Awarding office
Radius Health, Inc
Recipient
Nov 12, 2021
PoP end
$154K
Obligated
$154K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Radius Health, Inc — $90

Contract facts

Federal
Contract number36C77022F0026
Also listed as36C770-22-F-0026
Also listed as36F79718D0363-36C77022F0026
AgencyNational Cmop Office (36C770)
Awarding officeNational Cmop Office (36C770)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentRadius Health, Inc
CAGE7VA71
UEIXWM2P8FKM1Y5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79718D0363
Place of performanceLAKE MARY FL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startNov 2, 2021
PoP end (current)Nov 12, 2021
Obligated$154K
Current value$154K
Potential value$154K

ABALOPARATIDE is a federal award for National Cmop Office (36C770) held by Radius Health, Inc. Estimated value $154K ($154K obligated). Current period of performance ends Nov 12, 2021. Last award drew 1 bidder. Place of performance: LAKE MARY FL.

Recompete timing

Public
Past PoP end (1743 days ago)

Current PoP ended Nov 12, 2021 (1743 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 36C77022F0026?

36C77022F0026 (Abaloparatide) is a National Cmop Office (36C770) award with a potential value of $154K, currently held by Radius Health, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-22-F-0026?

36C770-22-F-0026 is the dashed form of PIID 36C77022F0026 (Abaloparatide), held by Radius Health, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77022F0026?

National Cmop Office (36C770) awarded 36C77022F0026 to Radius Health, Inc (potential $154K).

Who is the incumbent on 36C77022F0026?

Radius Health, Inc is the incumbent. The current period of performance ends Nov 12, 2021.

When does Radius Health, Inc’s 36C77022F0026 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 12, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C77022F0026